EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Iron status and low dose intravenous FeGluconate in hemodialysis patients on maintenance erythropoietin



Iron status and low dose intravenous FeGluconate in hemodialysis patients on maintenance erythropoietin



Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 272A, Sept




(PDF emailed within 1 workday: $29.90)

Accession: 032045144

Download citation: RISBibTeXText



Related references

Appropriate intravenous iron maintenance dosage in erythropoietin-treated hemodialysis patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 403A-404A, September, 2001

Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin. Clinical Nephrology 48(1): 63-64, 1997

Once weekly low dose intravenous iron dextran improves the erythrogenic response to erythropoietin in iron deficient hemodialysis patients. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 221A, Sept, 1997

Long-term continuous low-dose intravenous irongluconate in hemodialysis patients on maintenance erythropoietin. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 306A, Sept, 1999

Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin. Nephron 80(3): 369-370, 1998

The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrology, Dialysis, Transplantation 16(7): 1416-1423, 2001

Intravenous iron administration during the maintenance period in erythropoietin-treated hemodialysis patients: a simple and effective method. Journal of the Medical Association of Thailand 88 Suppl 4(): S184-S188, 2006

The effect of intravenous iron dextran on erythropoietin dose in pediatric hemodialysis patients. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 262A, Sept, 1999

Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. Renal Failure 24(2): 245-247, March, 2002

Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin: 1-year follow-up study. Nephron 86(2): 200-201, 2000

Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. Renal Failure 25(3): 445-453, 2003

Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 37(8): 844-848, 2014

Intravenous iron reduces erythropoietin use and improves iron indices in hemodialysis patients with functional iron deficiency. Journal of the American Society of Nephrology 14(Abstracts Issue): 706A, November, 2003

Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients. Clinical Nephrology 57(2): 136-141, 2002

Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients. American Journal of Kidney Diseases 31(5): 835-840, 1998